Taysha Gene Therapies, Inc.
TSHA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33 | -$27 | -$22 | -$19 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $3 | $3 | $3 |
| Change in WC | $6 | $2 | -$5 | -$3 |
| Other Non-Cash | -$1 | $1 | $0 | -$0 |
| Operating Cash Flow | -$24 | -$20 | -$22 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | $0 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $216 | $0 | -$0 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $0 | -$0 | $0 |
| Financing Cash Flow | $9 | $216 | -$0 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15 | $196 | -$22 | -$19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $315 | $119 | $142 | $160 |
| End Cash | $300 | $315 | $119 | $142 |
| Free Cash Flow | -$24 | -$20 | -$22 | -$18 |